1 human intervention study from report of the eu reviewers (midterm review 14-02-2002, brussels)...
TRANSCRIPT
1
Human Intervention Study
From Report of the EU reviewers (Midterm review 14-02-2002, Brussels)
“The human studies need careful thought otherwise there is a danger of the project appearing to have failed simply because it did not provide the hoped for cure for heart
disease and cancer”
2
Human Intervention Study
History
- Garlic would influence lipid metabolism / atherosclerosis
- Proposed study:
- 2 * 24 apparently healthy subjects with increased risk (mildly hypercholesterolemic, smoking)
- parallel trial (24 garlic / 24 placebo)
- biochemical measures lipid metabolism / inflammation
3
Human Intervention Study
Current situation:
- No indications that ‘garlic’ influences lipid metabolism
(human) intervention study without rationale is unethical; previous proposal not feasible
- New situation requires evaluation; other type of intervention study
4
Human Intervention Study
Considerations:
- Indications that ‘garlic’ may influence inflammation
- Cardiovascular disease (atherosclerosis; AS) shares common features with inflammation; CRP is primary endpoint
- Current treatment strategies for AS also focus on inflammation (for example: lipid lowering drugs; statins)
5
Human Intervention Study
Garlic and Inflammation/Atherosclerosis
- parallel design; 3 groups (n=30); risks groups; high doses!!
1. garlic powder (Kwai / EU??)
2. aged garlic extract (Kyolic??)
3. control
power = 0.87- 0.72 for 30 - 25% CRP-reduction
6
Human Intervention Study
- Garlic powder (Kwai / EU??)
- all compounds present in fresh garlic / sulphur-rich compounds (Alliin) preserved
- Aged garlic extract (Kyolic??)- fermented garlic (S-allyl cystein)
7
Human Intervention Study
- Recruitment: advertisements
- Medical screening
- 2-week run-in period
- Duplicate sampling (10-14 days apart) / measurements
- Randomisation
- Duplicate sampling / measurements
HALF-WAY (6 wks) & END treatment period (12 wks)
8
Garlic and Inflammation
- Biomarkers for inflammation- C-Reactive Protein (!!)
- Fibrinogen
- Cytokines after whole blood stimulation with LPS (TNF-; IL-10)
- Biomarkers for endothelial function- von Willebrand Factor
9
Additional biomarkers; atherosclerosis
- Clinical measures (ECG / HRV / BP)
- Routine lab (chol / HDL-C / triglyc / LDH etc.)
- PAI / s-VCAM / s-ICAM / s-Selectine
- SAA
- ox-LDL (plasma) / isoprostanes (urine)
- soluble CD40L (platelets)
10
Additional biomarkers; atherosclerosis
- IL-18 (IL-6)
- mRNA - leukocytes - gene array
- (Metabolites) of garlic compounds in urine (and blood?)
11
Additional biomarkers; other
Cancer biomarkers- phase II enzymes as glutathione S-transferase and quinone reductase (plasma and lymphocytes)
- DNA damage (lymphocytes) - comet assay
- Anti-mutagenic properties (urine) - Ames test
12
Points to discuss
- Design-Positive control? (statin)
- Study group Characteristics- mildly obese, smokers, postmenopausal women
- Intervention material and supplier- Lichtwer and Wakanuga?; EU-preparation?)
- Dosages- 6 g/day aged garlic extract / 2-4 g garlic powder
13
Points to discuss
- Questions
- is there a garlic effect?
- is it dependent on the preparation?
- Are these the questions we want to answer?